Novo Nordisk expands AI partnership with Valo Health for development of obesity drugs
2025-01-08Reuters
Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to develop new treatments for cardiometabolic diseases using human data and artificial intelligence (AI). ...Read more
